Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Athersys, Inc.
Athersys to Participate in the H.C. Wainwright Global Investment Conference
May 13, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports First Quarter 2022 Results
May 06, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Announce First Quarter Financial Results on May 6
April 29, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports That Its Partner, HEALIOS K.K., Provides Updates on MultiStem® Clinical Programs in Japan
April 04, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Participate in Two Upcoming Investor Conferences
April 01, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
March 15, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Year-End 2021 Financial Results Call
February 15, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host a Virtual Presentation on Its MultiStem® Programs
January 26, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer
January 20, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine
November 30, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports Third Quarter 2021 Results and Provides Corporate Update
November 15, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Third Quarter Financial Results Call
October 18, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Present at 2021 Cell & Gene Meeting on the Mesa Hybrid Conference
September 28, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
August 10, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports Second Quarter 2021 Results
August 09, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study
August 06, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Second Quarter Financial Results Call
July 13, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications
June 30, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports First Quarter 2021 Results
May 06, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host First Quarter Financial Results Call
April 13, 2021
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.